Search
Powered By HealthLine
Special Offers
TV Specials
 Learn about an Effective Alzheimer's Medication
 Bipolar Education Health Center
 Osteoarthritis of the Knee Solution Center
 Heartburn Education Center
 Breast Cancer Health Center
 Crohn's Disease Health Center
 Schizophrenia Education Center
Top Features
 Depression
 Schizophrenia
 Breast Cancer
 Bipolar
Resources
Healthscout News
3D Health Animations
Health Videos
Quizzes & Tools
Health Encyclopedia
In-Depth Reports
Library & Communities
News Archive
Drug Library
Find a Therapist
Enter City or Zip Code:
Powered by Psychology Today
PR Newswire
 Read latest







Channels
Home |  Today | Women| Men| Kids| Seniors| Diseases| Addictions| Sex & Relationships| Diet, Fitness, Looks| Alternative Medicine| Drug Checker
 Printer Friendly  Send to a Friend

Proposal to Give FDA More Muscle Gets Mixed Reviews


Related Encyclopedia
 border=
Acidophilus
Antioxidants
Caffeine (and its effects)
Calcinosis
More...

Related Healthscout Videos
 border=
Power Out Fat
Soy - Many Forms, Many Benefits
Soy - Health Benefits Explained
Diabetes: One Step Closer To A Cure
More...

Related Drug Information
 border=
Klor-Con
Klor-Con ER
More...

Related News Articles
 border=
Pregnancy and Work Can Work
Special Diet Can Ease Epileptic Seizures in Kids
Obesity May Worsen Impact of Asthma
Too Few Cancer Survivors Pursue Healthy Lifestyles
More...


Page:  << Prev | 1 | 2 | 3

The user fees Lurie referred to are part of the Prescription Drug User Fee Act (PDUFA), passed by Congress in 1992 to establish user fees paid by the drug companies to the FDA to review and vote on new drug applications.

The system of fees established by PDUFA would have expired Sept. 30 without action by Congress. That action came on Wednesday when the Senate voted to give the FDA broader enforcement powers as part of the Food and Drug Administration Revitalization Act.

The House of Representatives is expected to pass its own version of the bill.

Text Continues Below



The changes in the Senate bill are the culmination of years of mounting concern about drug safety in the United States, and they incorporate many recommendations from the Institute of Medicine.

Some drug manufacturers favor the new provisions.

The Generic Pharmaceutical Association called the Senate bill "a step in the right direction for providing consumers with greater access to safe and affordable generic medicines."

Sen. Edward M. Kennedy, D-Mass., the chief sponsor of the bill, said: "This landmark legislation creates a stronger Food and Drug Administration and sets forth a new and better direction for the safety of drugs we take and the food we eat. Almost half of all Americans take at least one pill a day, so this legislation will make a difference in the life of every American family. From prescription drugs to pacemakers to chemotherapy to the food we eat, the FDA protects the health of hundreds of millions of Americans --- often in ways we barely realize."

Sen. Michael B. Enzi, R-Wyoming, and ranking member of the Senate Health, Education, Labor and Pensions Committee, said: "Right now, the FDA has its hands tied behind its back when it tries to manage the risks of drugs already on the market. This bill will clarify and strengthen the FDA's authority and give it new tools to take measured and appropriate steps to protect the health and safety of Americans when the agency's post-market surveillance signals potential dangers from a drug or therapy."

More information

Learn more about the Prescription Drug User Fee Act at the U.S. Food and Drug Administration.

Page:  << Prev | 1 | 2 | 3

Copyright © 2007 ScoutNews, LLC. All rights reserved.
Last updated 5/10/2007

Related Links
 border=
From Healthscout's partner site on diet & exercise, MyDietExercise.com
QUIZ: What's your ideal body weight?
QUIZ: Check your body mass index (BMI) online!
QUIZ: Rate your carbohydrate intake





New Features

New ADHD Site!

SOURCES: Peter Lurie, M.D., deputy director, Public Citizen's Health Research Group, Washington, D.C.; A. Mark Fendrick, M.D., professor, internal medicine, University of Michigan School of Medicine, and professor, health management and policy, University of Michigan School of Public Health, Ann Arbor; Steven E. Nissen, M.D., chairman, Department of Cardiovascular Medicine, Cleveland Clinic Foundation, and immediate past president, American College of Cardiology; May 10, 2007, statement, Generic Pharmaceutical Association, Arlington, Va.


About The HealthScout Network Contact Us
Copyright © 2001-2009. The HealthCentralNetwork, Inc. All rights reserved.
Privacy Policy  Terms of Service   Site Map